Cargando…
Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update
BACKGROUND: Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive inborn error of cholesterol metabolism syndrome with neurocognitive manifestations. SLOS is the result of mutations in the gene encoding the 7-dehydrocholesterol reductase, which results in the elevation of the cholesterol precu...
Autores principales: | Thurm, Audrey, Tierney, Elaine, Farmer, Cristan, Albert, Phebe, Joseph, Lisa, Swedo, Susan, Bianconi, Simona, Bukelis, Irena, Wheeler, Courtney, Sarphare, Geeta, Lanham, Diane, Wassif, Christopher A., Porter, Forbes D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822234/ https://www.ncbi.nlm.nih.gov/pubmed/27053961 http://dx.doi.org/10.1186/s11689-016-9145-x |
Ejemplares similares
-
A Placebo-Controlled Trial of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
por: Wassif, Christopher A., et al.
Publicado: (2016) -
Smith-Lemli-Opitz-syndrome
por: Gedam, Rachana, et al.
Publicado: (2012) -
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness
por: Kovarova, Martina, et al.
Publicado: (2006) -
Smith-Lemli-Opitz Syndrome: Bosnian and Herzegovinian Experience
por: Begic, N, et al.
Publicado: (2021) -
Smith-Lemli-Opitz-syndrome: How different is the anesthetic technique?
por: Govindarajan, Srinivasa Raghavan, et al.
Publicado: (2014)